Replies to post #30970 on Intellipharmaceutics International Inc. (IPCI)

[tilator]

However, longer term, things don't look that bad. Unless MNK unexpectedly ends the deal somehow , Seroquel revenue should steady increase come 2018. They might get to break even but another ANDA approval is actually more important than Rexista right now. The stock needs to that moral boost.

This is quite much how I think about it too.

We should remember IPCI has four approved ANDAs already. They definitely know what it takes to get them approved. That's why we need not to be totally pessimistic about those pending ANDAs.

More ANDAs might end up to be the safest way to increase company value.